Cerberus Therapeutics is a platform company developing innovative immunological solutions for antigen specific tolerance and infectious diseases. Unlike traditional approaches that rely on suppressing immune responses or simply targeting immunogenic regions of the pathogens, our pioneering technology empowers the system to engage its own broad and complex network, leading the immune system to re-wire itself.

Small. But mighty.

Cerberus exploits an alpaca-derived single domain antibody fragment (VHH) to create two distinct platform technologies for immune modulation.